Ideanomics Balance Sheet Health
Financial Health criteria checks 0/6
Insufficient data to determine the health of Ideanomics
Key information
n/a
Debt to equity ratio
n/a
Debt
| Interest coverage ratio | n/a |
| Cash | n/a |
| Equity | n/a |
| Total liabilities | n/a |
| Total assets | n/a |
Recent financial health updates
Recent updates
Ideanomics: A High-Risk Speculative Play with Long-Term Potential
Current Take on Ideanomics (IDEX):At present, Ideanomics (IDEX) is a high-risk stock with significant challenges:Financial Instability:The company is experiencing large losses, reflected in its negatMarket Cool On Ideanomics, Inc.'s (NASDAQ:IDEX) Revenues Pushing Shares 36% Lower
Apr 17
Ideanomics: Investing In EV Is A Waiting Game
Oct 20Ideanomics, Solectrac secured new business contracts to supply electric tractors to major fleet operators
Oct 04Ideanomics to establish in-house design capabilities
Sep 26Ideanomics adds new dealers for Solectrac e-tractors
Sep 19Ideanomics reports Q2 GAAP EPS of -$0.08, revenue of $34.2M
Sep 09Ideanomics GAAP EPS of -$0.57, revenue of $114.08M
Sep 02Ideanomics' Solectrac adds new dealer partners in Florida and Ohio
Aug 02Solectrac, an operating company of Ideanomics partners with Nolan manufacturing to meet increasing electric tractor demands
Jul 12Ideanomics: A High-Risk EV Play
Jan 18Ideanomics Has Potential For Powerful Long-Term Growth And Diversification
Nov 29Does Ideanomics (NASDAQ:IDEX) Have A Healthy Balance Sheet?
Oct 28Financial Position Analysis
Short Term Liabilities: Insufficient data to determine if IDEX.Q's short term assets cover its short term liabilities.
Long Term Liabilities: Insufficient data to determine if IDEX.Q's short term assets cover its long term liabilities.
Debt to Equity History and Analysis
Debt Level: Insufficient data to calculate IDEX.Q's net debt to equity ratio to determine if it is satisfactory.
Reducing Debt: Insufficient data to determine if IDEX.Q's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: Insufficient data to determine if IDEX.Q's debt is well covered by operating cash flow.
Interest Coverage: Insufficient data to determine if IDEX.Q's interest payments on its debt are well covered by EBIT.
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/05 13:32 |
| End of Day Share Price | 2025/10/03 00:00 |
| Earnings | 2023/12/31 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Ideanomics, Inc. is covered by 3 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Andres Sheppard-Slinger | Cantor Fitzgerald & Co. |
| Jaywant Srivatsa | Chardan Capital Markets, LLC |
| Craig Irwin | Roth Capital Partners |